SIGNATUREFD, LLC - HEPION PHARMACEUTICALS INC ownership

HEPION PHARMACEUTICALS INC's ticker is HEPA and the CUSIP is 426897104. A total of 47 filers reported holding HEPION PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 1.20 and the average weighting 0.0%.

Quarter-by-quarter ownership
SIGNATUREFD, LLC ownership history of HEPION PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$2
+100.0%
20.0%0.00%
Q4 2022$120.0%0.00%
Q3 2022$020.0%0.00%
Q2 2022$020.0%0.00%
Q1 2022$020.0%0.00%
Q4 2021$020.0%0.00%
Q3 2021$020.0%0.00%
Q2 2021$020.0%0.00%
Q1 2021$020.0%0.00%
Q4 2020$020.0%0.00%
Q3 2020$020.0%0.00%
Q2 2020$020.0%0.00%
Q1 2020$020.0%0.00%
Q4 2019$020.0%0.00%
Q3 2019$020.00%
Other shareholders
HEPION PHARMACEUTICALS INC shareholders Q1 2021
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 306,338$564,0000.11%
PVG ASSET MANAGEMENT CORP 14,140$26,018,0000.08%
GSA CAPITAL PARTNERS LLP 160,775$296,0000.05%
Virtu Financial LLC 179,030$329,0000.02%
Allen Capital Group, LLC 23,685$44,0000.01%
McAdam, LLC 36,641$67,0000.01%
SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) 10,000$18,0000.01%
ZEKE CAPITAL ADVISORS, LLC 50,000$92,0000.01%
JGP Wealth Management, LLC 15,000$28,0000.01%
Onex Canada Asset Management Inc. 40,000$74,0000.00%
View complete list of HEPION PHARMACEUTICALS INC shareholders